Peter Jeffrey Conn

Director/Board Member at Appello Pharmaceuticals, Inc.

Health Technology

Profile

Peter Jeffrey Conn is the founder of Karuna Therapeutics, Inc. which was founded in 2009.
Currently, he holds a position as a Director at Appello Pharmaceuticals, Inc.

Peter Jeffrey Conn active positions

Companies	Position	Start
Appello Pharmaceuticals, Inc. Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN.	Director/Board Member	-

All active positions of Peter Jeffrey Conn

Former positions of Peter Jeffrey Conn

Companies	Position	End
KARA THER	Founder	-

See the detail of Peter Jeffrey Conn's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Jeffrey Conn's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Karuna Therapeutics, Inc. Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.	Health Technology
Appello Pharmaceuticals, Inc. Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN.	Health Technology